These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11395971

  • 1. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.
    Tanner JE, Alfieri C.
    Transpl Infect Dis; 2001 Jun; 3(2):60-9. PubMed ID: 11395971
    [Abstract] [Full Text] [Related]

  • 2. The biology of Epstein-Barr virus in post-transplant lymphoproliferative disease.
    Hsieh WS, Lemas MV, Ambinder RF.
    Transpl Infect Dis; 1999 Sep; 1(3):204-12. PubMed ID: 11428990
    [Abstract] [Full Text] [Related]

  • 3. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM, Krams SM.
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [Abstract] [Full Text] [Related]

  • 4. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Sep; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus: evasive maneuvers in the development of PTLD.
    Snow AL, Martinez OM.
    Am J Transplant; 2007 Feb; 7(2):271-7. PubMed ID: 17229074
    [Abstract] [Full Text] [Related]

  • 6. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 7. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
    Caduff N, McHugh D, Murer A, Rämer P, Raykova A, Landtwing V, Rieble L, Keller CW, Prummer M, Hoffmann L, Lam JKP, Chiang AKS, Raulf F, Azzi T, Berger C, Rubic-Schneider T, Traggiai E, Lünemann JD, Kammüller M, Münz C.
    PLoS Pathog; 2020 Apr; 16(4):e1008477. PubMed ID: 32251475
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
    Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner PH, Swinnen JL, Woodle ES, Bromberg JS.
    Transplantation; 1999 Nov 27; 68(10):1517-25. PubMed ID: 10589949
    [Abstract] [Full Text] [Related]

  • 10. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 27; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 11. Genomic variations in EBNA3C of EBV associate with posttransplant lymphoproliferative disorder.
    Maloney EM, Busque VA, Hui ST, Toh J, Fernandez-Vina M, Krams SM, Esquivel CO, Martinez OM.
    JCI Insight; 2020 Mar 26; 5(6):. PubMed ID: 32213705
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.
    Overkamp M, Granai M, Bonzheim I, Steinhilber J, Schittenhelm J, Bethge W, Quintanilla-Martinez L, Fend F, Federmann B.
    Virchows Arch; 2021 Jun 26; 478(6):1135-1148. PubMed ID: 33324999
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A, Spieker T, Mottok A, Baur AS, Küppers R, Hansmann ML.
    Eur J Immunol; 2003 Jun 26; 33(6):1593-602. PubMed ID: 12778477
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus, rapamycin, and host immune responses.
    Krams SM, Martinez OM.
    Curr Opin Organ Transplant; 2008 Dec 26; 13(6):563-8. PubMed ID: 19060543
    [Abstract] [Full Text] [Related]

  • 15. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment.
    Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A.
    Cancer Lett; 2015 Dec 01; 369(1):37-44. PubMed ID: 26279520
    [Abstract] [Full Text] [Related]

  • 16. Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.
    Faro A.
    Springer Semin Immunopathol; 1998 Dec 01; 20(3-4):425-36. PubMed ID: 9870255
    [Abstract] [Full Text] [Related]

  • 17. In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications.
    Gonzalez-Farre B, Rovira J, Martinez D, Valera A, Garcia-Herrera A, Marcos MA, Sole C, Roue G, Colomer D, Gonzalvo E, Ribera-Cortada I, Araya M, Lloreta J, Colomo L, Campo E, Lopez-Guillermo A, Martinez A.
    Mod Pathol; 2014 Dec 01; 27(12):1599-611. PubMed ID: 24762547
    [Abstract] [Full Text] [Related]

  • 18. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
    Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P.
    Transpl Infect Dis; 2005 Dec 01; 7(3-4):133-6. PubMed ID: 16390402
    [Abstract] [Full Text] [Related]

  • 19. Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.
    Davis JE, Sherritt MA, Bharadwaj M, Morrison LE, Elliott SL, Kear LM, Maddicks-Law J, Kotsimbos T, Gill D, Malouf M, Falk MC, Khanna R, Moss DJ.
    Int Immunol; 2004 Jul 01; 16(7):983-9. PubMed ID: 15159377
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder.
    Basgoz N, Preiksaitis JK.
    Infect Dis Clin North Am; 1995 Dec 01; 9(4):901-23. PubMed ID: 8747772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.